Clinical Trials

Our participation in clinical trials

At NJRetina, our physicians are actively involved in research as part of a host of multicentered clinical trials on new therapeutic approaches to retinal diseases. We have participated in a numerous national eye research studies, including:

Date PublishedStudyDiseaseLocationAccepting Patients?
June 16, 2017TOGA (Univ. of Virginia)Central NJYes
June 16, 2017Alimera "Paladin" M-01-15-004Central NJNo
June 16, 2017Score 2 CRVO (Penn State)Central NJNo
June 16, 2017Santen 32-009Central NJNo
June 16, 2017Regeneron RUBYCentral NJNo
June 16, 2017Regeneron ONYXCentral NJNo
June 16, 2017Alcon "Hawk" AMD RTH-258-C001Central NJNo
June 16, 2017OHR 1601Central NJNo
June 16, 2017Genentech Omaspect GX30191 EXTCentral NJYes
June 16, 2017Clearside "Tybee" CLS1004-201Northern NJYes
June 16, 2017Clearside "Sapphire" CLS1003-301Northern NJYes
June 16, 2017Allergan "Cedar" 150998-005Northern NJNo
June 16, 2017Roche "Avenue" BP29647Northern NJNo
June 12, 2017Vitreomacular Adhesion StudiesNorthern NJNo
June 12, 2017Non-exudative “Dry” Age-Related Macular Degeneration (AMD) StudiesNorthern NJNo
June 12, 2017Neovascular “Wet” Age-Related Macular Degeneration (AMD) StudiesNorthern NJNo
June 12, 2017Diabetic Retinopathy StudiesNorthern NJNo
June 12, 2017Retinal Vein OcclusionNorthern NJNo
June 12, 2017Uveitis StudiesNorthern NJNo

To learn more about these clinical trials, visit www.clinicaltrials.gov

For patients interested in enrolling in a clinical trial

Numerous clinical trials are available to appropriate NJRetina patients for a variety of retinal conditions. If you are interested in determining if you might be eligible for a clinical trial, request an appointment at our office.